6505-01-147-9542 Norgestrel and ethinyl estradiol
One item DLA buys: its open requests for quotation, approved sources and past DLA awards.
Overview
National Stock Number record
- Open RFQs
- 1
- Next due November 18, 2026
- Last price paid
- …
- Standard price
- $225.15 per PG
- DLA's catalog price, not a price paid
- Approved sources
- 2
- Awards on record
- 79
- 2015 to 2026
- DLA demand
- –
Identification
- Item name
- Norgestrel and ethinyl estradiol
- FSC / PSC
- 6505 · Drugs and biologicals
- NSG (group)
- 65 · Medical/dental/veterinary eqpt/supp
- NIIN assigned
- 25-FEB-83
- Unit
- PG
- NSN
- 6505-01-147-9542
- NIIN
- 01-147-9542
Name, end product, NIIN date and unit: DLA's Federal Logistics Information System (PUB LOG). Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
Approved suppliers
Manufacturers and part numbers DLA has qualified for this item, and the part numbers in its catalog record
| Supplier | CAGE | CAGE status | Part status (RNCC / RNVC) | Supplier part # | Listed in |
|---|---|---|---|---|---|
| TEVA PHARMACEUTICALS USA, INC. | 3V8D7 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC00555-9049-58 | DLA approved-source file |
| MAYNE PHARMA COMMERCIAL LLC | 4HH72 | A (Active) | 3 (Design control reference) / 2 (An item-identifying number) | NDC51862-0564-06 | DLA approved-source file |
| TEVA PHARMACEUTICALS USA, INC. | 3V8D7 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | CRYSELLE | FLIS part list |
| MAYNE PHARMA COMMERCIAL LLC | 4HH72 | A (Active) | 5 (Secondary reference) / 1 (Not identify an item of production without the use of additional information) | LOW-OGESTREL | FLIS part list |
Source: DLA's approved-source file published with the RFQs and the part list of DLA's catalog record (FLIS). CAGE and part status are FLIS's codes with DLA's wording.
Pricing and awardees
Supply contracts
2 contracts DLA ordered this item under
| Award ID | Awardee | Awarding office | Ceiling | Ordering ends | Type | Multiple award | Orders | Last order |
|---|---|---|---|---|---|---|---|---|
| SPE2DX25D9900 | DMS PHARMACEUTICAL GROUP INC | SPE2DX | $19,999,999 | March 6, 2038 | INDEFINITE DELIVERY / REQUIREMENTS | No | 14 | August 9, 2026 |
| SPE2DX15D9383 | DMS PHARMACEUTICAL GROUP INC | SPE2DX | $4,999,999 | December 31, 2025 | INDEFINITE DELIVERY / INDEFINITE QUANTITY | No | 17 | November 29, 2018 |
Source: DLA's procurement history files (the contract each order was placed under), the item's newest 2,000 award lines, joined to FPDS by the contract number. Multiple award, ordering period and ceiling are FPDS's; DLA's files do not give them.
Characteristics
Government-defined characteristics of this item (FLIS)
Hazardous and environmental
- Hazardous material (HMIC)
- P (No information in hmirs)
Product characteristics
| Code | Requirement | Description |
|---|---|---|
| AKJA | Active medicament medicinal strength | MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT 0.030 AND MILLIGRAMS NORGESTREL ACTIVE INGREDIENT 0.300 |
| CSGS | Administration | ORAL |
| MDES | Medical designation and grade | UNITED STATES PHARMACOPEIA |
| CXCY | Part name assigned by controlling agency | NORGESTREL AND ETHINYL ESTRADIOL TABLETS USP 168S PG |
| CRLK | Primary container content quantity | TABLETS 28.000 |
| FEAT | Special features | 28 TABLETS PER CYCLE; 6 CYCLES PER PKG (TOTAL AMOUNT OF TABLETS 168) EACH CYCLE CONTAINS 21 TABLETS WITH ACTIVE INGREDIENTS, 7 TABLETS WITH INERT INGREDIENTS;BLISTER-TYPE PACKAGING;PRIMARY CONTAINER TYPE:DISPENSER,PLASTIC PLATFORM;SECONDARY CONTAINER TYPE:CASE HOLDER,PLASTIC;PRIMARY CONTAINER QTY PER SECONDARY CONTAINER:1 DISPENSER,PLASTIC PLATFORM STORE AT 20-25 DEG C (68-77 DEG F)(SEE USP CONTROLLED ROOM TEMPERATURE) |
| CSCW | Total primary container quantity | 6 |
| CSCX | Total secondary container quantity | 6 |
Additional identifiers
- II
- 0
- DEMIL
- A: No demilitarization required
- Precious metals (PMIC)
- A (Does not contain precious metal)
- Schedule B
- 3004310000 (Medicaments cont insulin but not cont antibiotics)
- PINC
- 0031276
- Criticality (CRIT CD)
- X
- On FedMall
- Yes
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
Major organizational entity (MOE) rules
How each service or agency buys and manages this item
| Rule | MOE | AMC | AMSC | NIMSC | IMC | AAC | DSOR |
|---|---|---|---|---|---|---|---|
| A911 | Army (DA) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item | ||||
| FSGM | Air Force (DF) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item | ||||
| N9BL | Navy (DN) | 1Suitable for competition (second or later time) | ZCommercial or off-the-shelf item |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). AMC and AMSC wording: DFARS PGI 217.7506. Hover a code for DLA's wording.
Government organizations
The services and agencies that manage or use this item
| Organization | Effective date | Unit of issue | Unit price | Qty per unit | Controlled inventory | Shelf life | Acquisition advice | Source of supply |
|---|---|---|---|---|---|---|---|---|
| Army (DA) | 01-OCT-2025 | PG | $162.25 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Air Force (DF) | 01-OCT-2025 | PG | $162.25 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| Navy (DN) | 01-OCT-2025 | PG | $162.25 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
| DLA (DS) | 01-OCT-2026 | PG | $225.15 | 1 (1) | U (Unclassified) | M (24 months) | L (Local purchase) | SMS (Defense logistics agency) |
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP). Unit prices are DLA's standard prices (its catalog price to its customers, with DLA's surcharge), not prices DLA paid.
Packaging
FLIS packaging data of this item
FLIS packaging
- Level A
- Z (Special requirement)
- Level B
- Z (Special requirement)
- Unit container
- ZZ (Special requirement)
Source: DLA's PUB LOG files (FLIS Data Electronic Reading Room), updated monthly; code wording from DLA's code table (P_HELP).
DIBBS RFQs
Recent DLA requests for quotation for this item on DIBBS, newest first: 1 open now
| Solicitation | NSN | Item name | Qty | Unit | Std. price | Last price | Est. value | Set-aside | Tech docs | Posted | Return by |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPE2DP27T0348DIBBS only | 6505-01-147-9542 | Norgestrel and ethinyl estradiol | 1 | PG | $225.15 per PG | … | … | No set-aside | No | November 12, 2026 | November 18, 20264 days left |
| SPE2DP26T5254DIBBS only | 6505-01-147-9542 | Norgestrel and ethinyl estradiol | 1 | PG | $225.15 per PG | … | … | No set-aside | November 11, 2026First seen | October 5, 2026Closed | |
| SPE2DP26T5355DIBBS only | 6505-01-147-9542 | Norgestrel and ethinyl estradiol | 1 | PG | $225.15 per PG | … | … | No set-aside | November 11, 2026First seen | October 5, 2026Closed | |
| SPE2DP27T0003DIBBS only | 6505-01-147-9542 | Norgestrel and ethinyl estradiol | 1 | PG | $225.15 per PG | … | … | No set-aside | November 11, 2026First seen | October 7, 2026Closed | |
| SPE2DP26T4894DIBBS only | 6505-01-147-9542 | Norgestrel and ethinyl estradiol | 1 | PG | $225.15 per PG | … | … | No set-aside | November 3, 2026First seen | September 8, 2026Closed |
→ These RFQs in the DIBBS list
“First seen”: an RFQ from DIBBS's file of all open RFQs, which gives no issue date. Source: the request-for-quotation (RFQ) files DLA publishes on DIBBS each day. An RFQ that is also a SAM.gov notice links to that notice. Return-by dates are DIBBS's.
DLA forecast
DLA's purchase forecast for the next 24 months, and its lead time
DLA's own figures
- Lead time
- administrative 15 days, production 113 days (128 in all)
Source: DLA's monthly files in its FOIA reading room: the 24-month demand forecast (what DLA expects to buy, not a commitment) and the ALT/PLT file (administrative lead time: requirement to award; production lead time: award to delivery).
DLA award history
79 award lines since 2015, 2 winning CAGEs
| Winner | Awards | Last award |
|---|---|---|
| 1UNB0DMS PHARMACEUTICAL GROUP INC | 76 | August 9, 2026 |
| 0AG09SZY HOLDINGS, LLC | 3 | September 15, 2026 |
| Year | Awards | Winning CAGEs |
|---|---|---|
| 2026 | 15 | 2 |
| 2025 | 1 | 1 |
| 2024 | 4 | 1 |
| 2023 | 11 | 1 |
| 2022 | 8 | 1 |
| 2021 | 5 | 1 |
| 2020 | 3 | 1 |
| 2019 | 4 | 1 |
| 2018 | 17 | 1 |
| 2017 | 2 | 1 |
| 2016 | 5 | 1 |
| 2015 | 4 | 1 |
Source: DLA's award history files (its FOIA reading room: every DLA award line since 2013, refreshed monthly), plus the past awards listed in this item's RFQ documents that those files lack. Counts are award lines, not dollars; surplus buys are left out.
DLA awards for this item
25 awards from the item's award history, in FPDS
| Rank | Vendor | Obligated | |
|---|---|---|---|
| 1 | DMS PHARMACEUTICAL GROUP INC | $23,066 | 75 |
| 2 | SZY HOLDINGS, LLC | $208 | 1 |
| Contract | Awarded | Awardee | Obligated |
|---|---|---|---|
| SPE2DP26F8869From the item's award history | August 9, 2026 | DMS PHARMACEUTICAL GROUP INC | $356 |
| SPE2DP26F8565From the item's award history | July 31, 2026 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP26F8456From the item's award history | July 30, 2026 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP26F7629From the item's award history | July 14, 2026 | DMS PHARMACEUTICAL GROUP INC | $237 |
| SPE2DP26F6617From the item's award history | June 17, 2026 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP26F6307From the item's award history | June 3, 2026 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP26F5246From the item's award history | May 1, 2026 | DMS PHARMACEUTICAL GROUP INC | $237 |
| SPE2DP26F4818From the item's award history | April 21, 2026 | DMS PHARMACEUTICAL GROUP INC | $356 |
| SPE2DP26F4149From the item's award history | April 6, 2026 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP26F3523From the item's award history | March 12, 2026 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP26F3205From the item's award history | March 2, 2026 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP26F2777From the item's award history | February 9, 2026 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP26F2009From the item's award history | January 26, 2026 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP26F1669From the item's award history | January 13, 2026 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP25F9831From the item's award history | July 16, 2025 | DMS PHARMACEUTICAL GROUP INC | $356 |
| SPE2DP24F4167From the item's award history | April 22, 2024 | DMS PHARMACEUTICAL GROUP INC | $474 |
| SPE2DP24F4200From the item's award history | April 22, 2024 | DMS PHARMACEUTICAL GROUP INC | $1,186 |
| SPE2DP24F4026From the item's award history | April 16, 2024 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP24F2151From the item's award history | January 29, 2024 | DMS PHARMACEUTICAL GROUP INC | $237 |
| SPE2DP24F0298From the item's award history | October 17, 2023 | DMS PHARMACEUTICAL GROUP INC | $1,423 |
| SPE2DP24F0303From the item's award history | October 17, 2023 | DMS PHARMACEUTICAL GROUP INC | $237 |
| SPE2DP23F5244From the item's award history | July 31, 2023 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP23F4518From the item's award history | June 13, 2023 | DMS PHARMACEUTICAL GROUP INC | $119 |
| SPE2DP23F4381From the item's award history | June 3, 2023 | DMS PHARMACEUTICAL GROUP INC | $156 |
| SPE2DP23F4270From the item's award history | June 1, 2023 | DMS PHARMACEUTICAL GROUP INC | $156 |
Showing 1 to 10 of 25 results
Source: DLA award notices on SAM.gov for solicitations that included this item (DLA posts them above $25,000), and the contracts of this item's past DLA awards (DLA's award history files and the RFQs' procurement history), joined to FPDS by contract number (an order under a long-term contract by the order and its contract). Amounts are FPDS obligations; DIBBS order totals are not shown. Department of Defense actions appear in FPDS about 90 days after they are signed.